80例健康青年分别经针刺或艾灸肺俞穴后的肺功能变化

目的：探讨针刺与艾灸肺俞穴对健康人肺功能的影响。方法：我们选择了20－22岁健康男性80例，随机分为针刺组和艾灸组各40例，于针刺，艾灸前和针刺，艾灸后10min测试用力肺活量（FVC），用力呼气量（FEV1．0），最大呼气中段流速（MMF），最大呼气流量（PEFR），75％，50％，25％肺活量时的最大呼气流速（V75，V50，V25），结果：显示经针刺和艾灸肺俞穴后2组FVC，FFV1．0均显著增加，P＜0．05，2组间比较针刺组FVC明显高于艾灸组，P＜0．05，而且艾灸组MMF，V25亦显著降低P＜0．05，结论：健康人经针刺和艾灸肺俞穴后均可使大气道阻力减少，肺容量增加，提示一定量的艾燃烧后的烟雾可使健康人肺功能受到影响，使肺的小气道收缩，出现阻塞性改变。     

艾灸"肺俞""膏肓"影响BLMA5诱导肺纤维化大鼠TGF-β1表达实验研究

目的:探索针灸阻抑肺纤维化的效应机制,为针灸介入肺纤维化防治提供实验依据.方法:将SD大鼠140只随机分为4组:空白组、模型组、艾灸组、泼尼松组,每组35只.气管内注入博莱霉素制作大鼠肺纤维化模型,造模后7 d开始治疗,以5 mg艾绒灸其双侧"肺俞""膏肓",每穴3壮,每天1次,10 d为一疗程,共治疗3个疗程后处死动物,采用PCR检测其转化生长因子β1(TGF-β1)mRNA表达.结果:肺组织TGF-β1mRNA表达分别为:空白组1.0258±0.0057,模型组2.8104±0.2905,艾灸组1.6174±0.1136,泼尼松组1.7176±0.1079.艾灸组、泼尼松组与模型组比较,P<0.01,艾灸组与泼尼松组比较,P>0.05.结论:艾灸"肺俞""膏肓"与泼尼松治疗均能显著抑制肺纤维化大鼠肺组织TGF-β1mRNA表达.     

风门穴与肺俞穴针刺安全深度及角度的应用解剖研究

采用钢针标定法和层次解剖法,在46具成年人尸体上,研究风门穴与肺俞穴的解剖结构和针刺深度及角度。结果显示:向下直刺的解剖结构依次是皮肤、浅筋膜、斜方肌、菱形肌、上后锯肌、竖脊肌、肋提肌、肋间内膜、胸内筋膜、肋胸膜,向下直刺的平均危险深度,风门穴为49.51 mm,肺俞穴为44.88 mm;向外下斜刺,当针体与矢状面夹角在20~25°时,危险深度最小;向内下斜刺,当针体与矢状面夹角大于20°时,比较安全。     

电针“肺俞”穴对慢性阻塞性肺疾病大鼠迷走神经放电的影响

目的 观察电针“肺俞”穴对慢性阻塞性肺疾病（chronic obstructive pulmonary disease, COPD)大鼠迷走神经放电的影响,初步探讨针刺治疗COPD的作用机制。方法 随机将40只SD大鼠分为正常组、正常电针组、模型组、模型电针组,后两组以香烟烟熏结合脂多糖气管滴注法复制COPD模型。观察各组大鼠支气管肺泡灌洗液(bronchoalveolar lavage fluid, BALF)和血浆中乙酰胆碱（acetylcholine, ACh）的含量,并取正常电针组、模型电针组大鼠的“肺俞”穴进行即刻电针治疗,观察电针前后大鼠迷走神经放电情况。结果 与电针前比较,正常电针组和模型电针组大鼠电针后颈部左侧迷走神经放电频率、面积和幅度均显著增加（P<0.05） 模型电针组大鼠电针前后颈部左侧迷走神经放电频率、面积和幅度差值显著大于正常电针组（P<0.05）。ACh在外周血浆中含量变化为：模型组显著高于正常组（P<0.05）,模型电针组显著高于正常电针组但显著低于模型组（P<0.05）。ACh在BALF中含量变化为：正常电针组显著高于正常组（P<0.05）,模型电针组显著高于正常电针组和模型组（P<0.05）。结论 电针“肺俞”穴可使COPD大鼠迷走神经放电增强,并促进肺局部ACh递质的释放。     

肺腧穴外治法治疗小儿肺炎的研究近况

概述了近几年小儿肺炎的肺腧穴外治法研究,介绍了敷贴疗法、经皮疗法、拔罐疗法、穴位注射疗法以及TDP-J照射疗法在临床的治疗效果,研究显示肺腧穴外治法药物作用于人体的剂量较小、方法简便、疗效好、副作用少,但目前对其实验室指标的研究等较少。     

针刺肺俞及四花穴对慢性支气管炎迁延期老年患者免疫球蛋白的影响

目的观察针刺肺俞及四花(膈俞和胆俞)穴对慢性支气管炎迁延期老年患者免疫球蛋白的影响。方法将60例老年慢性支气管炎迁延期患者随机分为治疗组和对照组,每组30例。两组均采用常规药物治疗,治疗组采用针刺肺俞及四花穴治疗,对照组采用口服蜜炼川贝枇杷膏治疗。分别观察两组治疗前后免疫球蛋白变化。结果治疗组治疗后免疫球蛋白各项指标(IgA、IgM、IgG)与同组治疗前比较,差异均具有统计学意义(P0.05)。治疗组治疗后免疫球蛋白各项指标与对照组比较,差异均具有统计学意义(P0.05)。结论针刺肺俞及四花穴对慢性支气管炎迁延期老年患者免疫球蛋白具有升高作用。     

艾灸关元、肺俞穴治疗肺结核合并慢性疲劳综合征疗效观察

目的：观察艾灸关元、肺俞穴治疗肺结核合并慢性疲劳综合征（chronic fatigue syndrome,CFS）的疗效。方法：将80例肺结核合并CFS患者随机分为治疗组（40例）和对照组（40例）,两组患者均给予常规药物治疗,治疗组则在常规治疗基础上采用艾条温和灸关元、肺俞穴,4周为一个疗程,一个疗程后采用多维疲劳问卷（Multidimensional Fatigue Inventory,MFI-20）评定疗效。结果：治疗组总体疲劳、生理疲劳、精神疲劳、活动减少、兴趣减少等MFI-20评分均显著低于对照组（P〈0.01）。结论：艾灸关元、肺俞穴治疗肺结核合并CFS疗效显著,值得临床推广应用。     

艾灸肺俞、心俞治疗慢性心衰临床观察

目的观察艾灸配合西药治疗慢性心衰的临床疗效。方法将60例患者随机分为对照组和治疗组,每组30例。对照组给予西药常规治疗;治疗组在西药常规治疗的基础上,采用艾条温和灸双侧肺俞、心俞穴,每穴灸治20 min,每日1次,共灸治4星期。比较两组治疗后临床疗效和心功能相关指标。结果对照组总有效率为76.7%,治疗组总有效率为90.0%,治疗组优于对照组（P〈0.05）;两组治疗后HR、CO、LVEF较治疗前有显著改善（P〈0.01）,治疗组治疗后HR、CO、LVEF与对照组比较有显著差异（P〈0.01）,治疗组治疗后HR、CO、LVEF改善状况优于对照组。结论艾灸配合西药治疗慢性心衰临床疗效优于单纯西药治疗。     

Effect of scar-producing moxibustion at the acupoints Zusanli (ST 36) and Feishu (BL 13) on neutrophil-to-lymphocyte ratio and quality of life in patients with non-small-cell lung cancer: A randomized,controlled trial

OBJECTIVE

To evaluate the effect of heat stimulation via scar-producing moxibustion at the acupoints Zusanli (ST 36) and Feishu (BL 13) on the neutrophil-to-lymphocyte ratio (NLR) and quality of life in patients with non-small-cell lung cancer (NSCLC).

Electroacupuncture at Feishu (BL13) and Zusanli (ST36) down-regulates the expression of orexins and their receptors in rats with chronic obstructive pulmonary disease

OBJECTIVE: Infl ammation and lung function decline are the main pathophysiological features of chronic obstructive pulmonary disease(COPD). Acupuncture can improve lung function in patients with COPD, but the underlying mechanisms are not well understood. Orexins(OXs), which are found in peripheral plasma, are neuropeptides that regulate respiration and their levels are related to COPD. Therefore, we hypothesized that acupuncture might alter OXs, reduce lung infl ammation and improve lung function in COPD.METHODS: COPD was induced in rats by exposure to cigarette smoke for 8 weeks and injecting with lipopolysaccharide twice. Electroacupuncture(EA) was performed at Feishu(BL13) and Zusanli(ST36) for 30 min/d for 2 weeks. Rat lung function and morphology were assessed after EA. The levels of tumor necrosis factor-α(TNF-α) and interleukin-1β(IL-1β) in bronchoalveolar lavage fl uid(BALF) and orexin A and B levels in the lung tissue were detected by enzyme-linked immunosorbent assay. OX receptor mRNA levels and immunopositive cells were assessed with real-time polymerase chain reaction and immunohistochemical methods, respectively. The relationships among lung function, cell factors, and OX levels were analyzed by Pearson correlation analyses.RESULTS: Compared with the control group, lung function was signifi cantly decreased in the rats with COPD(P0.05). There were obvious increases in TNF-α and IL-1β levels in BALF(P0.05 and P0.01, respectively), orexin A level in lung tissue(P0.01; but not orexin B) and mRNA expressions of OX 1 type receptor(OXR1) and OX 2 type receptor(OXR2) in lung tissue(P0.05 and P0.01, respectively); the integrative optical densities(IODs) of both receptors were greater in the COPD group(P0.05). For rats with COPD subjected to EA, lung function was improved(P0.05). There were notable decreases in TNF-α and IL-1β levels(P0.05 and 0.01, respectively) in BALF. Orexin A, but not orexin B, levels in lung tissue also decreased(P0.01), as did mRNA expression of OX1 R and OX2 R in lung tissue(P0.05 and P0.01, respectively). Receptor IODs were also reduced after EA treatment(P0.05). Furthermore, orexin A levels and ratio of forced expiratory volume in 0.3 s to forced vital capacity were strongly negatively correlated(P0.01), and orexin A was positively correlated with TNF-α and IL-1β(P0.001 and P0.05, respectively).CONCLUSION: EA at Zusanli and Feishu improved lung function of rats with COPD and had an anti-infl ammatory effect, which may be related to down-regulation of OXA and its receptors.